share_log

Senti Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Li Yvonne

Senti Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Li Yvonne

Senti Biosciences | 3:首次持股声明-高管 Li Yvonne
美股sec公告 ·  05/09 16:27
Moomoo AI 已提取核心信息
Yvonne Li, the Interim CFO of Senti Biosciences, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated May 4, 2024, indicates that Li does not beneficially own any securities in the company. The form, signed by attorney-in-fact Mike Rhee on May 9, 2024, is a standard disclosure for officers, directors, and certain beneficial owners under Section 16(a) of the Securities Exchange Act of 1934. This filing is particularly relevant for investors as it provides transparency regarding the ownership stakes of key company insiders.
Yvonne Li, the Interim CFO of Senti Biosciences, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated May 4, 2024, indicates that Li does not beneficially own any securities in the company. The form, signed by attorney-in-fact Mike Rhee on May 9, 2024, is a standard disclosure for officers, directors, and certain beneficial owners under Section 16(a) of the Securities Exchange Act of 1934. This filing is particularly relevant for investors as it provides transparency regarding the ownership stakes of key company insiders.
根据表格3的要求,Senti Biosciences, Inc.的临时首席财务官Yvonne Li已向美国证券交易委员会提交了初步的证券实益所有权声明。该文件日期为2024年5月4日,表明李不以实益方式拥有该公司的任何证券。该表格由事实上的律师迈克·李于2024年5月9日签署,是根据1934年《证券交易法》第16(a)条向高级管理人员、董事和某些受益所有人提供的标准披露。该文件对投资者尤其重要,因为它为公司主要内部人士的所有权提供了透明度。
根据表格3的要求,Senti Biosciences, Inc.的临时首席财务官Yvonne Li已向美国证券交易委员会提交了初步的证券实益所有权声明。该文件日期为2024年5月4日,表明李不以实益方式拥有该公司的任何证券。该表格由事实上的律师迈克·李于2024年5月9日签署,是根据1934年《证券交易法》第16(a)条向高级管理人员、董事和某些受益所有人提供的标准披露。该文件对投资者尤其重要,因为它为公司主要内部人士的所有权提供了透明度。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息